Nancy Liu-Sullivan
Papers
1
Total Citations
2
H-Index
1
About
Dr. Nancy Liu-Sullivan is a pivotal figure in translational drug discovery, best known for her foundational work in establishing and advancing high-throughput screening (HTS) platforms at Memorial Sloan Kettering Cancer Center (MSKCC). Her primary research focus lies in the development of integrated, collaborative screening infrastructures that bridge chemical biology and functional genomics. Her most cited work, "Chemical & RNAi Screening at MSKCC: A Collaborative Platform to Discover & Repurpose Drugs to Fight Disease" (2014), details the creation of MSKCC’s state-of-the-art High-Throughput Screening Core Facility (HTSCF). This landmark paper, with 2 citations, describes the deployment of modern robotics and custom-built data management resources designed to rapidly store and query vast chemical and RNAi screening datasets. By architecting this full-service platform, Dr. Liu-Sullivan enabled researchers to systematically repurpose existing drugs and discover novel therapeutic agents, significantly accelerating the pace of preclinical discovery. Her contributions have been instrumental in democratizing access to high-throughput technologies, fostering a collaborative ecosystem that empowers scientists to fight disease more efficiently.
Research Focus
Key Achievements
Top Papers
- 1